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ABSTRACT 
Background and Purpose 
The association of socioeconomic status (SES) with quality of stroke care is not well 
understood and few studies have examined the association with different indicators of SES 
simultaneously. We assessed the impacts of low levels of education, occupation and income 
on the quality of stroke care. 
Methods 
We examined data from the China National Stroke Registry recording consecutive stroke 
patients between September 2007 and August 2008. Baseline low SES was measured using 
educational level <6 years, occupation as manual workers or no job and average family 
income per capita at ≤¥1,000 per month. Compliance with 11 performances was summarized 
in a composite score defined as the proportion of all needed care given. Poor quality of care 
was defined as having a composite score of 0.71 or less.  
Results 
Among 12,270 patients with ischemic stroke, 38.6% had <6 educational years, 37.6% manual 
workers/ no job and 34.7% income ≤¥1000 per month. There was an increased chance of 
receiving poor quality of care in patients with low education [adjusted odds ratio: 1.15, 95% 
confidence interval: 1.03-1.28], low occupation (1.16, 1.01-1.32) and low income (1.18, 1.06-
1.30), respectively. People with low SES had poor performances on some aspects of care 
quality. Combined effects existed among these SES indicators; those with low SES from all 3 
indicators had the poorest quality of care.  
Conclusions  
There was a social gradient in the quality of stroke care. Continuous efforts of socioeconomic 
improvement will increase the quality of acute stroke care. 
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INTRODUCTION 
Stroke is the leading cause of disability and the second cause of death in the world.
1, 2
 There 
is evidence that increased quality of care during the early phase of stroke is significantly 
associated with reduced risk of disability and mortality.
3
 However, the quality of stroke care 
has varied globally; high income countries have better quality of stroke care than low and 
middle income countries,
4, 5
 and even in the same country inequalities in stroke care exist 
across populations.  
Although stroke patients with low socioeconomic status (SES) have an increased 
mortality
6-8
 and poorer functional recovery,
9
 the association between SES and quality of 
stroke care remains unclear. Recent findings from the UK suggest that lower socioeconomic 
status was associated with reduced odds of being admitted to hospital (stroke unit or 
otherwise).
10
 The association was also found in other studies undertaken in high income 
countries.
11-13
 However, other studies
14, 15
 did not detect such a social gradient association. 
These inconsistent findings may be due to different measurements of the quality of stroke 
care and SES. Few studies have used levels of education, occupation and income or other 
SES indicators simultaneously to examine their associations with quality of stroke care. It is 
unknown whether there are interactions and combined effects of these SES indicators on the 
quality of stroke care. There is lack of data from low- and middle-income countries, where 
quality of stroke care is much poorer and stroke mortality is higher than these in high income 
countries.
5, 16, 17
 The association of SES with the quality of stroke care has not been well 
studied. In this paper, we examined a large cohort data from China to assess the impacts of 
SES indicated by levels of education, occupational class and average family income per 
capita on quality of care in stroke patients. 
METHODS 
Study Participants 
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The study participants were derived from the China National Stroke Registry (CNSR).
18
 
Details of the design and baseline characteristics of the CNSR have been published 
previously.
18
 In brief, the CNSR is a nationwide, multicenter, prospective registry study 
including consecutive patients with acute cerebrovascular events from 132 hospitals covering 
27 provinces and 4 municipalities across China between September 2007 and August 2008. 
The survey included 22,216 patients with acute cerebrovascular events who aged ≥18 years 
and presented to hospital within 14 days after onset. After excluding patients with 
“undetermined” diagnosis, those transferred from other hospitals, those with missing or 
incomplete information at baseline and those who did not consent for participation and 
follow-up, 18580 patients were included in the CNSR, of which 12415 were ischemic strokes. 
The details of these selection is shown in Figure 1. Acute ischemic stroke was diagnosed 
according to the World Health Organization criteria
19
 and confirmed by magnetic resonance 
imaging or brain computerized tomography. Etiology of ischemic stroke was classified 
according to the TOAST (Trial of Org 10172 in Acute Stroke Treatment) criteria.
20
 The data 
collection of the CNSR study was approved by ethics committee at Beijing Tiantan Hospital 
and all centers. Written informed consent was given by all patients or his/her representatives 
before being entered into the study. 
Baseline SES and other risk factors measurement 
Data on demographics, SES, cardiovascular risk factors and other baseline information were 
collected through face-to-face interviews by trained interviewers (neurologists). We 
documented the details of educational level, occupational class and average family income in 
each patient.
21
 Educational level was recorded to 5 groups according to the educational year: 
“>12 years”, “10-12 years”, “6-9 years”, “1-5 years” and “illiteracy”. Occupational class was 
determined as “non-manual workers”, “manual workers”, “no job” or “retired” based on their 
main job title. Income level was recorded to 6 groups according to the average family income 
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per capita per month (ie, the family’s actual income per month is divided by the number of 
family members): “<¥500”, “¥500-¥1000”, “¥1001-¥3000”, “¥3001-¥5000”, “¥5001-
¥10000”, and “>¥10000”. We recorded cardiovascular risk factors, history of diseases, stroke 
severity according to the National Institutes of Health Stroke Scale (NIHSS) score and pre-
stroke modified Rankin Scale (mRS) scores (dichotomized to >1 and ≤1). Patients who were 
lack of knowledge of medical history or risk factor were clarified as “unknown”. The data of 
teaching/non-teaching hospital and total beds of the hospital were also collected. 
Quality of care 
Our trained interview team used the 9 GWTG-Stroke performance measures and 2 additional 
evidence-based interventions (antihypertensive and antidiabetic agents at discharge)
22, 23
 to 
document the care of stroke for each of patients with acute ischemic stroke. It includes (1) 
intravenous recombinant tissue plasminogen activator (IV rt-PA) in patients who arrived <2 
hours after symptom onset with no contraindications; (2) antithrombotic medication within 
48 hours of admission; (3) deep vein thrombosis (DVT) prophylaxis within 48 hours of 
admission if nonambulatory; (4) counseling or medication for smoking cessation if current 
smoker; (5) dysphagia screening prior to any oral intake during hospitalization; (6) 
rehabilitation services during hospitalization; (7) discharge on antithrombotics among those 
with no contraindications; (8) discharge on anticoagulants if atrial fibrillation present among 
those with no contraindications; (9) discharge on statins if dyslipidemia present, low-density 
lipoprotein (LDL) ≥100 mg/dL, or LDL not documented among those with no 
contraindications; (10) discharge on antihypertensive agents if hypertension present among 
those with no contraindications; and (11) discharge on antidiabetic agents if diabetes mellitus 
present among those with no contraindications. 
We calculated an opportunity-based composite score to reflect the summary composite 
measure of quality of stroke care for each patient. The composite score was defined as the 
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total number of above interventions performed in each patient divided by the total number of 




We included 12,270 ischemic stroke patients who had data of education, occupation or 
income in this study (Figure 1). We defined patients with <6 years education, manual 
laboring/ no job, or family income ≤¥1000 per month as having socioeconomic deprivation 
(SED).
21
 The national data showed that average family income per capita per month is ¥1,423 
in the urban area and ¥559 in the rural area of China in 2008 and approximately half of 
residents living with family income ≤¥1000 per month.25 Thus it would be reasonable for us 
to use the family income ≤¥1000 per month as SED for analysis. We divided patients into 3 
groups according to the tertiles of the composite score of the quality of care and took those 
who had low 2 tertiles of the score as having the poor quality of stroke care (because China 
has a generally poorer quality of stroke care than those in high income countries
5, 26
). We 
examined differences between patients with poor versus good quality of stroke care in 
continuous variables using t test or Wilcoxon rank sum test and in categorical variables using 
Chi-square test. We employed multivariate adjusted logistic regression models to compute 
odds ratio (OR) and its 95% confidence intervals for receiving the poor quality of stroke care 
in relation to SED. We adjusted patient’s individual-level and hospital-level covariates, 
including for age, gender, heavy alcohol drinking, previous stroke, pre-stroke mRS, stroke 
subtype, NIHSS on admission, teaching hospital and total beds of hospital. We also created a 
hospital level variable that reflected the proportion of stroke patients who were classified as 
SED, and then added it to the models to control for poor performing hospitals. Apart from the 
composite score, we examined each of 11 performances measured in the quality of care in 
relation to SES to identify urgent specific areas for improving the quality of care after stroke. 
As the 3 SES indicators in China would not be highly correlated with each other (eg, some 
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Chinese people were richer but had a low education), we investigated interaction effects 
between 2 indicators on these specific performances. We examined the combined effects 
from 3 indicators (scores summed up from each of SED) on the quality of stroke care and 
tested a social gradient trend in terms of the 3 SES indicators’ cumulative impact. 
Missing values for education, occupational class and income level were imputed using 
multiple imputation techniques. We generated 5 imputed data sets replacing each missing 
value with a set of plausible values, and then combined the ORs with their 95% CIs across 
the 5 imputations with adjustment of standard errors to account for the additional uncertainty 
introduced by the imputation. Missing values for other covariates were not imputed using 
multiple imputation approaches but treated as a separate group in the models. Multilevel 
approaches in logistic regression models were performed considering the clustering effect at 
the hospital level. Using the same approaches, we carried out a sensitivity analysis to 
examine complete data without imputation. 
    All analyses were performed with SAS software version 9.3 (SAS Institute Inc, Cary, NC). 
RESULTS 
Among the 12,415 patients, 145(1.2%) were excluded for not having any data of educational 
level, occupational class or income. The baseline characteristics of those included and 
excluded were well balanced (Table I in the online-only Data Supplement). In 12,270 patients, 
their average age was 65.5 (range 18-100), 38.2% were female. 38.6% had educational level 
<6 years, 37.6% were manual workers/ jobless, and 34.7% had family income ≤¥1000 per 
capita per month. The median composite score of the patients was 0.60 with an interquartile 
range of 0.40-0.80, and the tertiled score points were 0.50 and 0.71. 
Table 1 shows numbers and percentages of SES variables in patients receiving good or 
poor quality of stroke care. Patients with the poor quality of stroke care were more likely to 
have low levels of SES. We also observed that they were more likely to be older and never 
STROKE/2016/013292_R3    Pan  Page 7 
smoke, have atrial fibrillation and previous stroke, higher pre-stroke disability, cardio-
embolism and higher NIHSS score, and hospitalize in teaching hospitals or hospitals with less 
total beds, but less diabetes mellitus. There were no significant differences in sex, heavy 
drink, hypertension, dyslipidemia and coronary heart disease between two groups of patients 
(Table II in the online-only Data Supplement). 
Table 2 shows numbers and adjusted ORs of poor quality of stroke care in relation to each 
individual of 3 SED indicators. Patients with educational level of <6 years had an increased 
odds of receiving the poor quality of stroke care (adj.OR: 1.15, 95%CI: 1.03-1.28). This was 
similar in patients with manual working or no job (adj.OR: 1.16, 95%CI: 1.01-1.32), and with 
averaged person family income of ≤¥1000 per month (adj.OR: 1.18, 95%CI: 1.06-1.30). 
We examined the association between SED and compliance with individual performance 
indicators of quality of stroke care, and found that patients with low education were less 
likely to receive DVT prophylaxis <48 hours after admission, dysphagia screening, statins 
and antihypertensive agents at discharge (Table 3). Patients with low occupational class were 
less likely to receive antithrombotic and antihypertensive agents at discharge, while those 
with low income were less likely to receive dysphagia screening, rehabilitation services, 
antithrombotic agents and statins at discharge. Rates of IV rt-PA treatment, antithrombotics 
<48 hours after admission, smoking cessation, antidiabetic agents and anticoagulants at 
discharge were similar across SES subgroups (Table 3). Possible reasons for non-treatment in 
each indicator were listed in Table III in the online only Supplement and only valid 
contraindication excluded patients from each measure according to the definition of 
performance measures. 
Interactions and combined effects of educational level, occupational class and income on 
the 11 performance measurement of the quality of stroke care were showed in Table IV, 
Table V and Table VI in the online-only Data Supplement. Table 4 shows the combination of 
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3 SED indicators in relation to poor quality of care. There was a social gradient association of 
SED with receiving poor quality of care. Patients with a score of 2 and 3 had around 1.2- and 
1.4-fold of odds to receive the poor quality of care with a trend p <0.001. 
The sensitivity analyses using the complete data without SES variables imputed showed 
similar findings; for example in Table 2: 1.17 (1.05-1.29) in educational level of <6 years, 
1.17 (1.04-1.33) in manual workers or no job, and 1.12 (1.01-1.26) in income of ≤1000 RMB, 
while in Table 4: 1.13 (0.98-1.30) and 1.37 (1.15-1.63) in patients with a SED score of 2 and 
3, respectively. 
DISCUSSION 
In this large-scale national stroke registry study, we found that low levels of education, 
occupation and income were simultaneously associated with receiving poor quality of care in 
patients with ischemic stroke. There was evidence that the higher SED the patients had the 
lower quality of care they received.  
The association of SES with the quality of stroke care has also been observed in some 
studies undertaken in high incomes countries. A population-based registry in Denmark 
reported that individuals with low SES were associated with a lower chance of receiving 
optimal acute stroke care.
11
 Results from the Registry of the Canadian Stroke Network 
showed that higher income was associated with improvements in some aspects of stroke care 
delivery, such as stroke unit admission and referrals to secondary prevention clinics.
13
 
However, other studies for example from the UK and Netherlands did not show a significant 
association between SED and poor provision of stroke care.
14, 15, 27
 This may be because these 
studies
14, 15, 27
 had small sample sizes, only used one dimension of SES (education or 
occupation, respectively) and had a limited measurement of stroke care. Our CNSR study 
demonstrated that there were significant individual and combined effects of low level of 
education, occupational class and income on receiving high quality of stroke care. 
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China has experienced rapid economic growth since its economic reform in 1978 and has 
had a large increase in income inequality between the rich and poor over the past 30 years.
28
 
The Gini coefficient (a most commonly used measure of inequality of income or wealth; a 
Gini coefficient of 0 expresses perfect equality and 1 expresses maximal inequality) for 
family income in China was reported to have now reached a level above 0.5,
28
 comparing to 
0.36 in the USA and 0.358 in the UK.
29
 The quality of stroke care in China is diverse across 
the country and on the whole poorer than that in western countries, especially for rt-PA 
treatment and warfarin use.
5, 26
 Knowledge of existing disparities in the quality of stroke care 
is of importance for improving outcomes of stroke patients. Our study has shown that patients 
with SED have poorer quality of stroke care. The results would help target subgroups of 
stroke patients who would most likely benefit from interventions. We consider that general 
socioeconomic improvement and targeting groups with SED is likely to improve the quality 
of stroke care provision and then increase better outcomes of stroke. Our results may serve as 
a relevant reference for reducing inequality in health care, particularly in the low- and 
middle- income countries. 
The findings of the current study may also help explain an association between SED and 
an increased mortality after stroke.
6-8
 The possible mechanisms of SED increasing mortality 
could be through poorer quality of health-care provision, apart from patient’s higher risk-
factor prevalence and severity of stroke.
11, 30
 The current study showed that patients with SED 
received poorer quality of some aspects of acute and secondary preventive care of stroke. 
These could be applied to target high risk groups of stroke patients to improve the prognosis. 
Patients with low educational or income level might possibly be admitted to low-level 
hospitals, where services fall below standards of care because of lack of awareness—for 
example, providing dysphagia screening before any oral intake for stroke patients. We thinkg 
that providers may not recommend evidence-based therapies to patients if there was  
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perception that the patient would  not be able to pay for them, whether or not patient refusal. 
Furthermore, we consider that patients with SED wereboth unaware and lacking in economic 
capability to accept rehabilitation services and the evidence-based secondary preventive 
interventions of stroke, e.g., statins, antithrombotic and antihypertensive agents at discharge. 
Apart from reforming the current system of stroke care, including access to services, we urge 
the Chinese governments to increase educational level and reduce the poverty in population 
to improve the likelihood that high quality stroke care will be affordable and attainable by the 
majority of  Chinese citizens. 
Strengths and weaknesses of the study 
The strength of the current study is that the CNSR is a large scale national representative 
registry study, which was used to evaluate the quality of stroke care over time and its 
determinants.
18
 It includes patients with a diversity of socioeconomic characteristics and 
hospitals with disparities in quality of stroke care, which reflects the high level of 
socioeconomic inequalities in China.
21
 The unique data has helped us examine separate, 
interactions and combined impacts of the 3 SES indicators on quality of stroke care. We used 
multiple imputation techniques to deal with missing data. Even in a high rate of missingness 
such as “income” at about 20%, the multiple imputation technique is valid.31 Therefore, our 
findings of the association between 3 SED indicators and quality of stroke care are robust. 
Our study has limitations. First, the CNSR does not cover rural hospitals, and thus we could 
not examine differences in the quality of stroke care between the rural and urban areas. 
Previous studies showed that rural hospitals have an overall poorer quality of care than urban 
hospitals.
32
 Thus the associations of low quality of stroke care with SED in this study may be 
under-estimated. Second, of 22,216 patients, 1437 did not consent to follow up and were 
excluded for analysis. A study from the Canadian Stroke Registry suggested that excluding 
those patients could improve the performance since they were more likely to be with higher 
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severity.
33
  However, our CNSR data had only 6.5% of patients who did not consent to follow 
up and thus the effects of bias on the findings would be minimized. Third, we took patients 
with low two-thirds of the composite score for the poor quality of care in analysis. The cut-
off point is arbitrary, based on our understanding that stroke patients in China have a poorer 
quality of stroke care in China than those in high income countries.
5, 26
 However, if we used 
the median score of 0.6 or below defined as having a  poor quality of care for data analysis, 
the findings were similar to the current ones (data now shown). Fourth, there might be some 
stroke patients who did not search for care from hospital or died before hospitalization. 
Although they are estimated to be very low, these rates also could be socioeconomic 
patterned; those with lower level of SES may be less likely to be admitted to hospitals and 
receive care from the hospitals.
10
 Thus, the findings of our current study could be more 
conservative. 
CONCLUSIONS 
In conclusions, the China nationwide stroke register study has demonstrated that low 
levels of education, occupation and income were significantly associated with receiving poor 
quality of care in patients with ischemic stroke. Continuous efforts to reduce socioeconomic 
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FIGURE LEGENDS 
 
Figure 1. Patient flow diagram. 
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TABLES 





Quality of acute stroke care 
p value Good quality of 
care (N=4208) 
Poor quality of 
care (N=8062) 
Educational level (years), n(%)     
>12 1180(9.6) 435(10.3) 745(9.2) <0.001 
10-12 2248(18.3) 816(19.4) 1432(17.8)  
6-9 2922(23.8) 1074(25.5) 1848(22.9)  
1-5 3061(25.0) 1023(24.3) 2038(25.3)  
Illiteracy 1666(13.6) 471(11.2) 1195(14.8)  
   Unknown 1193(9.7) 389(9.2) 804(10.0)  
Occupational class, n(%)     
Non-manual workers 1972(16.1) 744(17.7) 1228(15.2) <0.001 
Manual workers 3308(27.0) 1031(24.5) 2277(28.2)  
No job 1303(10.6) 402(9.5) 901(11.2)  
Retired 5244(42.7) 1868(44.4) 3376(41.9)  
Unknown 443(3.6) 163(3.9) 280(3.5)  
Personal income (RMB/month), n(%)     
>10000 21(0.2) 10(0.2) 11(0.1) <0.001 
5001-10000 140(1.1) 74(1.8) 66(0.8)  
3001-5000 665(5.4) 288(6.8) 377(4.7)  
1001-3000 4160(33.9) 1663(39.5) 2497(31.0)  
500-1000 2852(23.2) 1020(24.2) 1832(22.7)  
<500 1407(11.5) 424(10.1) 983(12.2)  
   Unknown 3025(24.7) 729(17.3) 2296(28.5)  
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Table 2. Number and adjusted OR of poor quality of stroke care 
Socioeconomic status Nos of patients with 
poor quality of care/ 
total patients (%) 
Adj.OR
† 
(95% CI) p value 
Educational level (Years)    
 ≥6 4468/7009(63.7) 1  
   <6  3594/5261(68.3) 1.15(1.03- 1.28) 0.01 
Occupational class    
Non-manual workers 1278/2047(62.4) 1  
Manual workers or no job* 3282/4779(68.7) 1.16(1.01-1.32) 0.03 
Retired 3502/5444(64.3) 1.05(0.91-1.20) 0.50 
Income level (RMB/month)    
 >1000 4005/6447(62.1) 1  
   ≤1000 4057/5823(69.7) 1.18(1.06-1.30) 0.002 
CI indicates confidence interval; OR, odds ratio. 
*
 Manual workers: 2351/3430(68.5%), OR=1.16 (95%CI: 1.01-1.33), p=0.04; and in patients 
with no job: 931/1349(69.0%), OR=1.16 (95%CI: 0.97-1.38), p=0.10.  
†
 MI, multilevel modeling, adjusted for age, gender, heavy alcohol drinking, previous stroke, 
pre-stroke mRS, stroke subtype, NIHSS on admission, teaching hospital, total beds of 
hospital and a hospital level variable reflecting the proportion of patients classified as 
socioeconomic deprivation. 
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Table 3. Overall compliance with individual performance indicators among patients with ischemic stroke 
Quality of care – performance measures   Educational 
Level (Years) 
  Occupational class    Income Level 
(RMB/month) 
 ≥6 <6  Non-manual 
workers 
Manual workers or 
no job 
Retired  >1000 ≤1000 
IV rt-PA treatment % (N Eligible) 13.6(447) 8.7(266)  14.6(132) 8.4(206) 12.7(375)  13.5(434) 9.0(279) 
 OR(95% CI)* 1 0.57(0.26-1.27)  1 0.56(0.22-1.40) 1.19(0.54-2.63)  1 0.71(0.28-1.78) 
Antithrombotics <48 hours % (N Eligible) 83.7(6739) 82.7(5042)  84.1(1973) 84.8(4584) 81.6(5224)  84.0(6189) 82.5(5592) 
 OR(95% CI)* 1 0.97(0.86-1.10)  1 1.02(0.86-1.21) 0.99(0.83-1.18)  1 0.91(0.80-1.04) 
DVT prophylaxis <48 hours % (N Eligible) 65.7(2245) 62.2(2133)  60.6(572) 62.4(1841) 66.5(1965)  65.3(2294) 62.5(2084) 
 OR(95% CI)* 1 0.83(0.70-0.99)  1 0.95(0.75-1.21) 1.15(0.90-1.47)  1 0.94(0.75-1.17) 
Smoking cessation % (N Eligible) 73.0(2281) 66.0(1003)  73.3(767) 70.1(1368) 70.2(1149)  71.7(1713) 70.0(1571) 
 OR(95% CI)* 1 0.96(0.73-1.24)  1 0.98(0.75-1.28) 0.96(0.71-1.29)  1 0.97(0.78-1.20) 
Dysphagia screening % (N Eligible) 39.6(6520) 37.1(4746)  37.1(1926) 34.7(4355) 42.5(4985)  43.7(5937) 32.8(5329) 
 OR(95% CI)* 1 0.85(0.74-0.98)  1 1.01(0.86-1.18) 1.04(0.88-1.23)  1 0.76(0.67-0.86) 
Rehabilitation services % (N Eligible) 48.6(7009) 48.2(5261)  48.2(2047) 45.4(4779) 51.2(5444)  52.3(6447) 44.1(5823) 
 OR(95% CI)* 1 1.00(0.90-1.10)  1 0.98(0.86-1.12) 1.06(0.93-1.21)  1 0.83(0.75-0.92) 
Discharged on antithrombotics % (N Eligible) 71.2(6927) 67.9(5163)  75.0(2033) 70.6(4723) 67.1(5334)  71.8(6336) 67.6(5754) 
 OR(95% CI)* 1 0.96(0.86-1.08)  1 0.86(0.75-1.00) 0.95(0.81-1.11)  1 0.88(0.79-0.99) 
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Discharged on anticoagulants % (N Eligible) 25.6(371) 24.7(345)  28.6(83) 25.9(246) 23.9(387)  25.6(417) 24.5(299) 
 OR(95% CI)* 1 1.28(0.81-2.01)  1 1.14(0.57-2.26) 1.44(0.73-2.85)  1 0.77(0.44-1.36) 
Discharged on statins % (N Eligible) 33.6(2413) 29.4(1949)  36.1(665) 31.4(1803) 30.6(1894)  33.7(2278) 29.6(2084) 
 OR(95% CI)* 1 0.79(0.66-0.96)  1 0.80(0.63-1.02) 0.93(0.73-1.18)  1 0.84(0.71-0.99) 
Discharged on antihypertensive agents % (N Eligible) 53.7(4987) 49.6(3727)  56.9(1443) 50.8(3148) 51.1(4123)  53.9(4726) 49.6(3988) 
 OR(95% CI)* 1 0.87(0.77-0.98)  1 0.85(0.73-0.98) 0.95(0.82-1.11)  1 0.94(0.83-1.05) 
Discharged on antidiabetic agents % (N Eligible) 61.6(1945) 59.3(1379)  65.2(574) 60.4(1077) 59.2(1673)  61.8(1878) 59.2(1446) 
 OR(95% CI)* 1 1.19(0.98-1.44)  1 1.00(0.78-1.29) 0.96(0.75-1.23)  1 1.04(0.81-1.35) 
Composite score mean (SD)  0.58(0.26) 0.55(0.26)  0.59(0.25) 0.56(0.25) 0.57(0.27)  0.60(0.25) 0.54(0.27) 
CI indicates confidence interval; OR, odds ratio; IV rt-PA, intravenous recombinant tissue plasminogen activator; DVT, deep vein thrombosis; SD, Standard Deviation. 
* The same model and adjustment in Table 2. 
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Table 4. Number and adjusted OR of poor quality of stroke care in relation to SED 
combinations in patients with stroke 




Nos of poor quality of 
care/ patients (%) 
Adj.OR
†
 (95% CI) p value 
0 1995/3328(59.9) Ref.  
1 2537/3879(65.4) 1.07(0.95- 1.21) 0.25 
2 2193/3204(68.4) 1.17(1.03- 1.33) 0.02 
3 1337/1859(71.9) 1.39(1.19- 1.63) <0.001 
CI indicates confidence interval; OR, odds ratio; SED, socioeconomic deprivation. 
*
 Added scores from each of low levels of educational years <6 (1 score), manual workers or 
no jobs (1 score) and income ≤1000 RMB (1 score). 
†
 The same model and adjustment in Table 2. 
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SUPPLEMENTAL MATERIAL 
 
Table I. Comparison of baseline characteristics of the included and excluded groups 





Socio-demography    
Age (year), mean(SD) 65.5±12.3 65.1±12.6 0.46 
Sex, n(%)    
Men 7583(61.8) 75(51.7) 0.01 
Women 4687(38.2) 70(48.3)  
Medical history    
Hypertension, n(%)    
No 4339(35.4) 57(39.3) 0.16 
Yes  7714(62.9) 83(57.2)  
Unknown 217(1.8) 5(3.5)  
Diabetes mellitus, n(%)    
No 9405(76.7) 106(73.1) 0.41 
Yes  2607(21.2) 34(23.4)  
Unknown 258(2.1) 5(3.5)  
Dyslipidemia, n(%)    
No 8296(67.6) 102(70.3) 0.25 
Yes  1380(11.3) 10(6.9)  
Unknown 2594(21.1) 33(22.8)  
Coronary heart disease, n(%)    
No 10503(85.6) 120(82.8) 0.33 
Yes  1767(14.4) 25(17.2)  
Atrial fibrillation, n(%)    
No 10958(89.3) 131(90.3) 0.69 
Yes  1312(10.7) 14(9.7)  
Stroke case, severity and acute care    
Previous stroke, n(%)    
No 8083(65.9) 98(67.6) 0.67 
Yes  4187(34.1) 47(32.4)  
Subtype of stroke
*
, n(%)    
Large-artery atherosclerosis 5507(44.9) 80(55.2) 0.12 
Small-vessel occlusion 2066(16.8) 24(16.6)  
Cardioembolism 756(6.2) 7(4.8)  
Other or undetermined 453(3.7) 5(3.5)  
Unknown 3488(28.4) 29(20.0)  
NIHSS on admission, median(IQR)  4(2-9) 5(2-10) 0.67 
SD indicates Standard Deviation; IQR, Interquartile Range; mRS, modified Rankin Scale; 
NIHSS, National Institutes of Health Stroke Scale. 
* Stroke subtype was defined by the Trial of Org 10172 in Acute Stroke Treatment (TOAST) 
classification. 
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Table II. Characteristics of ischemic stroke patients and quality of acute stroke care in the 




Quality of acute stroke care 
p value Good quality of 
care (N=4208) 
Poor quality of 
care (N=8062) 
Socio-demography     
Age (year), mean(SD) 65.5±12.3 65.1±12.0 65.6±12.5 0.01 
Sex, n(%)     
Men 7583(61.8) 2640(62.7) 4943(61.3) 0.12 
Women 4687(38.2) 1568(37.3) 3119(38.7)  
Medical history and risk factors     
Smoking status, n(%)     
Never-smoking 7060(57.5) 2337(55.5) 4723(58.6) <0.001 
Former-smoking 1610(13.1) 557(13.2) 1053(13.1)  
Current smoking 3284(26.8) 1225(29.1) 2059(25.5)  
Unknown 316(2.6) 89(2.1) 227(2.8)  
Heavy drink, n(%)     
No 10763(87.7) 3678(87.4) 7085(87.9) 0.19 
Yes  1316(10.7) 473(11.2) 843(10.5)  
Unknown 191(1.6) 57(1.4) 134(1.7)  
Hypertension, n(%)     
No 4339(35.4) 1464(34.8) 2875(35.7) 0.33 
Yes  7714(62.9) 2661(63.2) 5053(62.7)  
Unknown 217(1.8) 83(2.0) 134(1.7)  
Diabetes mellitus, n(%)     
No 9405(76.7) 3125(74.3) 6280(77.9) <0.001 
Yes  2607(21.2) 985(23.4) 1622(20.1)  
Unknown 258(2.1) 98(2.3) 160(2.0)  
Dyslipidemia, n(%)     
No 8296(67.6) 2817(66.9) 5479(68.0) 0.45 
Yes  1380(11.3) 491(11.7) 889(11.0)  
Unknown 2594(21.1) 900(21.4) 1694(21.0)  
Coronary heart disease, n(%)     
No 10503(85.6) 3619(86.0) 6884(85.4) 0.36 
Yes  1767(14.4) 589(14.0) 1178(14.6)  
Atrial fibrillation, n(%)     
No 10958(89.3) 3841(91.3) 7117(88.3) <0.001 
Yes  1312(10.7) 367(8.7) 945(11.7)  
Stroke case, severity and acute care     
Previous stroke, n(%)     
No 8083(65.9) 2831(67.3) 5252(65.1) 0.02 
Yes  4187(34.1) 1377(32.7) 2810(34.9)  
Pre-stroke mRS >1, n(%)     
No 10952(89.3) 3800(90.3) 7152(88.7) 0.03 
Yes  1158(9.4) 359(8.5) 799(9.9)  
Unknown 160(1.3) 49(1.2) 111(1.4)  
Subtype of stroke
*
, n(%)     
Large-artery atherosclerosis 5507(44.9) 2185(51.9) 3322(41.2) <0.001 
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Small-vessel occlusion 2066(16.8) 902(21.4) 1164(14.4)  
Cardioembolism 756(6.2) 242(5.8) 514(6.4)  
Other or undetermined 453(3.7) 149(3.5) 304(3.8)  
Unknown 3488(28.4) 730(17.4) 2758(34.2)  
NIHSS on admission, median(IQR)  4(2-9) 4(2-8) 5(2-10) 0.004 
Teaching hospital, n(%)     
No 5458(44.5) 1934(46.0) 3524(43.7) 0.02 
Yes  6812(55.5) 2274(54.0) 4538(56.3)  
Total beds of hospital, median(IQR) 1026(700-1400) 1100(700-1600) 1000(700-1400) <0.001 
SD indicates Standard Deviation; IQR, Interquartile Range; mRS, modified Rankin Scale; 
NIHSS, National Institutes of Health Stroke Scale. 
* Stroke subtype was defined by the Trial of Org 10172 in Acute Stroke Treatment (TOAST) 
classification.  
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Table III. Possible reasons for non-treatment in each indicator 
Quality of care – performance measures Possible reasons 
IV rt-PA treatment Contraindications of IV t-PA (such as active 
internal bleeding, systolic blood pressure > 185 
mmHg or diastolic blood pressure > 110 
mmHg despite treatment, seizure at onset, 
recent surgery/trauma (within 15 days), history 
of intracranial hemorrhage or brain aneurysm 
or vascular malformation or brain tumor, et al) 
Patient/Family refused for economic reason 
Patient/Family refused for risk of bleeding 
IV t-PA was not available in this hospital 
Didn’t know patient needed to be treated 
Others 
Antithrombotics <48 hours Didn’t know patient needed to be treated 
Contraindications of antithrombotics (such as 
allergic, serious side effect of antithrombotic 
agents, concomitant diseases that cannot use 
antithrombotic agents, high risk for bleeding or 
discontinued due to bleeding, et al) 
Patient/Family refused 
Others 
DVT prophylaxis <48 hours Didn’t know patient needed to be treated 
Contraindications of anticoagulants (such as 
allergic, serious side effect of anticoagulant 
agents, concomitant diseases that cannot use 
anticoagulant agents, high risk for bleeding or 
discontinued due to bleeding, et al) 
Contraindications of thrombosis pump 
Patient/Family refused 
Physician didn’t know how to do 
Others 
Smoking cessation Didn’t know patient needed to be treated 
Patient’s condition not allowed 
Patient/Family refused 
Others 
Dysphagia screening Didn’t know patient needed to be treated 
Didn’t know how to evaluate it 
Symptom resolution 
Fasting 
Can’t be evaluated due to coma 
Others 
Rehabilitation services No facilities 
No personnel 
Didn’t know patient needed to be treated 
No permission due to patient’s condition 
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Patient/Family refused 
Others 
Discharged on antithrombotics Didn’t know patient needed to be treated 
Contraindications of antithrombotics (such as 
allergic, serious side effect of antithrombotic 
agents, concomitant diseases that cannot use 
antithrombotic agents, high risk for bleeding or 
discontinued due to bleeding, et al) 
Patient/Family refused 
Terminal illness/palliative care only 
Allergy 
Others 
Discharged on anticoagulants Didn’t know patient needed to be treated 
Didn’t know how to do 
Contraindications to anticoagulants (such as 
allergic, serious side effect of anticoagulant 
agents, concomitant diseases that cannot use 
anticoagulant agents, high risk for bleeding or 
discontinued due to bleeding, et al) 
Risk of bleeding 
Risk of falls 
Liver disease 
Terminal illness/palliative care only 
Patient/Family refused 
Others 
Discharged on statins Contraindications to lipid-lowering treatment 
(such as allergic, serious side effect of lipid-
lowering agents, concomitant diseases that 
cannot use lipid-lowering agents, et al) 
Didn’t know patient needed to be treated 
Patient/Family refused 
Others 
Discharged on antihypertensive agents Contraindications to antihypertensive treatment 
(such as allergic, serious side effect of 
antihypertensive agents, concomitant diseases 
that cannot use antihypertensive agents, et al) 
Didn’t know patient needed to be treated 
Patient/Family refused 
Others 
Discharged on antidiabetic agents Contraindications to antidiabetic treatment (such 
as allergic, serious side effect of antidiabetic 
agents, concomitant diseases that cannot use 
antidiabetic agents, et al) 
Didn’t know patient needed to be treated 
Patient/Family refused 
Others 
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Table IV. Overall compliance with individual performance indicators among patients with levels of education and income 
combined 
 High education and 
high income
* 
 High education and low income  Low education and high income  Low education and low income 
Quality of care – performance measures % (N 
Eligible) 
Ref   % (N 
Eligible) 
OR(95% CI)
†  % (N 
Eligible) 
OR(95% CI)




IV rt-PA treatment 15.2(302) Ref  10.3(145) 0.78(0.29-2.14)  9.7(132) 0.62(0.26-1.50)  7.6(134) 0.46(0.13-1.62) 
Antithrombotics <48 hours 84.9(3996) Ref  82.0(2743) 0.88(0.75-1.03)  82.4(2193) 0.94(0.78-1.13)  82.9(2849) 0.90(0.77-1.06) 
DVT prophylaxis <48 hours 67.5(1357) Ref  62.9(889) 0.96(0.70-1.30)  62.2(937) 0.83(0.66-1.05)  62.2(1195) 0.80(0.62-1.03) 
Smoking cessation 74.4(1300) Ref  71.1(981) 1.01(0.79-1.30)  62.9(413) 1.04(0.69-1.57)  68.2(590) 0.90(0.65-1.25) 
Dysphagia screening 44.7(3869) Ref  32.2(2651) 0.78(0.66-0.93)  41.9(2068) 0.89(0.74-1.08)  33.4(2678) 0.68(0.57-0.81) 
Rehabilitation services 51.8(4154) Ref  43.9(2856) 0.86(0.74-0.99)  53.1(2293) 1.07(0.92-1.24)  44.4(2967) 0.84(0.73-0.96) 
Discharged on antithrombotics 72.9(4096) Ref  68.7(2831) 0.93(0.79-1.10)  69.8(2240) 1.04(0.88-1.25)  66.5(2923) 0.86(0.75-0.99) 
Discharged on anticoagulants 24.3(242) Ref  27.9(129) 1.00(0.43-2.30)  27.4(175) 1.72(0.93-3.17)  21.9(170) 0.94(0.48-1.86) 
Discharged on statins 34.4(1433) Ref  32.4(980) 0.97(0.76-1.23)  32.5(845) 0.92(0.72-1.18)  27.1(1104) 0.68(0.54-0.86) 
Discharged on antihypertensive agents 55.5(3024) Ref  50.9(1962) 0.98(0.84-1.14)  51.1(1702) 0.91(0.77-1.07)  48.4(2025) 0.83(0.72-0.96) 
Discharged on antidiabetic agents 63.2(1214) Ref  59.0(731) 1.02(0.75-1.39)  59.2(664) 1.18(0.91-1.53)  59.4(715) 1.22(0.90-1.65) 
Composite score mean (SD) 0.61(0.25)   0.55(0.27)   0.58(0.26)   0.54(0.26)  
CI indicates confidence interval; OR, odds ratio; IV rt-PA, intravenous recombinant tissue plasminogen activator; DVT, deep vein thrombosis; SD, Standard Deviation.  
* High education: ≥6 years; high income: >1000 RMB/month; low education: <6 years; low income: ≤1000 RMB/month.  
† The same model and adjustment in Table 2.  
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Table V. Overall compliance with individual performance indicators among patients with levels of education and occupation 
combined  
 High education and high occupation*  High education and low occupation  Low education and high occupation  Low education and low occupation 
Quality of care – performance measures % (N Eligible) Ref   % (N Eligible) OR(95% CI)†  % (N Eligible) OR(95% CI)†  % (N Eligible) OR(95% CI)† 
IV rt-PA treatment 15.5(119) Ref  10.8(94) 0.60(0.21-1.69)  6.0(13) 0.14(0.00-124.3)  6.3(112) 0.35(0.10-1.19) 
Antithrombotics <48 hours 84.2(1693) Ref  85.5(1881) 1.04(0.84-1.29)  83.1(281) 0.88(0.57-1.39)  84.3(2703) 0.97(0.79-1.19) 
DVT prophylaxis <48 hours 61.2(469) Ref  63.6(649) 1.05(0.78-1.39)  58.2(103) 0.97(0.57-1.64)  61.7(1193) 0.86(0.65-1.15) 
Smoking cessation 73.5(690) Ref  73.9(804) 1.07(0.78-1.46)  70.7(77) 1.17(0.59-2.32)  64.7(563) 0.90(0.63-1.28) 
Dysphagia screening 38.1(1650) Ref  34.9(1809) 1.02(0.84-1.24)  30.9(276) 0.72(0.49-1.03)  34.5(2546) 0.89(0.73-1.07) 
Rehabilitation services 48.3(1755) Ref  45.1(1954) 0.95(0.82-1.12)  47.3(293) 0.96(0.68-1.35)  45.6(2825) 1.00(0.85-1.18) 
Discharged on antithrombotics 75.7(1742) Ref  72.2(1940) 0.88(0.74-1.06)  70.8(291) 0.91(0.63-1.31)  69.5(2783) 0.82(0.68-0.98) 
Discharged on anticoagulants 27.3(71) Ref  33.5(77) 1.40(0.57-3.47)  36.8(11) 2.41(0.40-14.42)  22.4(169) 1.24(0.56-2.78) 
Discharged on statins 36.8(569) Ref  34.4(713) 0.88(0.65-1.20)  31.8(96) 0.70(0.40-1.22)  29.3(1090) 0.66(0.49-0.88) 
Discharged on antihypertensive agents 56.4(1234) Ref  52.1(1241) 0.91(0.75-1.10)  59.8(209) 1.19(0.83-1.70)  49.9(1906) 0.81(0.68-0.98) 
Discharged on antidiabetic agents 65.2(483) Ref  61.5(429) 0.97(0.71-1.33)  65.1(91) 1.36(0.76-2.45)  59.7(648) 1.17(0.86-1.61) 
Composite score mean (SD) 0.60(0.25)   0.58(0.25)   0.57(0.25)   0.55(0.25)  
CI indicates confidence interval; OR, odds ratio; IV rt-PA, intravenous recombinant tissue plasminogen activator; DVT, deep vein thrombosis; SD, Standard Deviation.  
* High education: ≥6 years; high occupation: non-manual workers; low education: <6 years; low occupation: manual workers or no jobs.  
† The same model and adjustment in Table 2.   
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Table VI. Overall compliance with individual performance indicators among patients with levels of income and occupation 
combined  
 High income and high occupation*  High income and low occupation  Low income and high occupation  Low income and low occupation 
Quality of care – performance measures % (N Eligible) Ref   % (N Eligible) OR(95% CI)†  % (N Eligible) OR(95% CI)†  % (N Eligible) OR(95% CI)† 
IV rt-PA treatment 12.6(89) Ref  13.5(95) 1.21(0.31-4.70)  18.6(43) 1.90(0.39-9.32)  4.0(111) 0.31(0.08-1.23) 
Antithrombotics <48 hours 85.6(1239) Ref  84.0(1723) 0.93(0.72-1.19)  81.5(734) 0.82(0.63-1.08)  85.2(2861) 0.96(0.77-1.19) 
DVT prophylaxis <48 hours 61.6(361) Ref  62.5(664) 0.90(0.65-1.24)  59.0(211) 0.83(0.50-1.40)  62.3(1177) 0.89(0.64-1.24) 
Smoking cessation 75.3(486) Ref  68.6(545) 0.93(0.63-1.38)  69.8(281) 0.87(0.56-1.34)  71.1(822) 0.93(0.65-1.33) 
Dysphagia screening 41.3(1207) Ref  40.6(1635) 1.03(0.83-1.28)  30.0(719) 0.67(0.52-0.87)  31.1(2720) 0.77(0.63-0.94) 
Rehabilitation services 50.9(1288) Ref  48.9(1792) 0.97(0.81-1.17)  43.6(760) 0.83(0.65-1.07)  43.3(2987) 0.88(0.73-1.07) 
Discharged on antithrombotics 76.5(1278) Ref  73.1(1767) 0.95(0.78-1.15)  72.4(755) 0.96(0.75-1.23)  69.1(2955) 0.78(0.64-0.94) 
Discharged on anticoagulants 25.3(53) Ref  25.2(104) 1.42(0.54-3.74)  34.5(30) 1.17(0.35-3.88)  26.4(142) 1.07(0.44-2.59) 
Discharged on statins 37.3(430) Ref  34.5(675) 0.89(0.65-1.21)  33.9(235) 0.85(0.56-1.28)  29.5(1128) 0.68(0.49-0.95) 
Discharged on antihypertensive agents 67.6(904) Ref  51.9(1223) 0.87(0.71-1.07)  55.7(540) 1.04(0.80-1.35)  50.0(1925) 0.84(0.68-1.02) 
Discharged on antidiabetic agents 64.5(370) Ref  61.9(458) 1.12(0.78-1.61)  66.6(204) 1.26(0.79-1.99)  59.3(619) 1.07(0.76-1.51) 
Composite score mean (SD) 0.61(0.24)   0.58(0.25)   0.56(0.26)   0.55(0.25)  
CI indicates confidence interval; OR, odds ratio; IV rt-PA, intravenous recombinant tissue plasminogen activator; DVT, deep vein thrombosis; SD, Standard Deviation.  
* High income: >1000 RMB/month; high occupation: non-manual workers; low income: ≤1000 RMB/month; low occupation: manual workers or no jobs.  
† The same model and adjustment in Table 2.  
 
 
 
 
